Genetics testing company 23andMe received Food and Drug Administration clearance for its prostate cancer risk test. It’s 23andMe’s third clearance for a cancer risk report — the company also has tests for genes that predict breast and colorectal cancer risk. The test screens for a specific mutation on the HOXB13 gene linked with an increased …
Category: Uncategorized
23andMe Gets FDA Clearance for Prostate Cancer Risk Test
Genetics testing company 23andMe received Food and Drug Administration clearance for its prostate cancer risk test. It’s 23andMe’s third clearance for a cancer risk report — the company also has tests for genes that predict breast and colorectal cancer risk. The test screens for a specific mutation on the HOXB13 gene linked with an increased …
23andMe Gets FDA Clearance for Prostate Cancer Risk Test
Genetics testing company 23andMe received Food and Drug Administration clearance for its prostate cancer risk test. It’s 23andMe’s third clearance for a cancer risk report — the company also has tests for genes that predict breast and colorectal cancer risk. The test screens for a specific mutation on the HOXB13 gene linked with an increased …